Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Archives of Virology|February 13, 2021
Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemicAkeno Tsuneki-Tokunaga, Kyosuke Kanai, Asao Itagaki, et al.
Archives of Virology|November 11, 2021
Local spread of influenza A (H1N1) viruses without a mutation for the maximum duration of an epidemic season in JapanAkeno Tsuneki-Tokunaga, Takanori Kondo, Kyosuke Kanai, et al.
Human Pathology|February 1, 2011
Association of Merkel cell polyomavirus infection with morphologic differences in Merkel cell carcinomaSatoshi Kuwamoto, Hiromi Higaki, Kyosuke Kanai, et al.
Journal of Medical Virology|April 27, 2010
Epstein-Barr virus can infect rabbits by the intranasal or peroral route: an animal model for natural primary EBV infection in humansKeisuke Okuno, Kazuaki Takashima, Kyosuke Kanai, et al.
Virus Research|August 10, 2010
Lifelong persistent EBV infection of rabbits with EBER1-positive lymphocyte infiltration and mild sublethal hemophagocytosisKyosuke Kanai, Kazuaki Takashima, Keisuke Okuno, et al.
Autoimmunity|March 12, 2015
Reactivation of persistent Epstein-Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surfaceKeiko Nagata, Yuji Nakayama, Katsumi Higaki, et al.
Autoimmunity|January 29, 2014
Presence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individualsKeiko Nagata, Katsumi Higaki, Yuji Nakayama, et al.
International Journal of Molecular Sciences|July 12, 2025
Host-Virus Interface in Persistent SARS-CoV-2 Infections: Viral Characteristic Evolution and Gene Expression Profiling AnalysisAthok Shofiudin Maarif, Yukari Nishikawa, Miyako Takata, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2025
Rapid immunization and antibody redesign platform discovers broadly neutralizing antibodies against non-immunized SARS-CoV-2 variantShusei Hamamichi, Narumi Uno, Kazuto Shimoya, et al.
Pageof 3